Pregled bibliografske jedinice broj: 996116
Novel symmetric bis-benzimidazoles: Synthesis, DNA/RNA binding and antitrypanosomal activity
Novel symmetric bis-benzimidazoles: Synthesis, DNA/RNA binding and antitrypanosomal activity // European journal of medicinal chemistry, 173 (2019), 63-75 doi:10.1016/j.ejmech.2019.04.007 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 996116 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Novel symmetric bis-benzimidazoles: Synthesis,
DNA/RNA binding and antitrypanosomal activity
Autori
Bistrović Popov, Andrea ; Stolić, Ivana ; Krstulović, Luka ; Taylor, Martin C. ; Kelly, John M. ; Tomić, Sanja ; Tumir, Lidija-Marija ; Bajić, Miroslav ; Raić-Malić, Silvana
Izvornik
European journal of medicinal chemistry (0223-5234) 173
(2019);
63-75
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
bis-benzimidazoles ; ctDNA binding ; UV-Vis ; CD spectroscopy ; thermal denaturation ; Trypanosoma brucei
Sažetak
The novel benzimidazol-2-yl-fur-5-yl-(1, 2, 3)- triazolyl dimeric series with aliphatic and aromatic central linkers was successfully prepared with the aim of assessing binding affinity to DNA/RNA and antitrypanosomal activity. UV-Visible spectroscopy, thermal denaturation showed interaction of heterocyclic bis-amidines with ctDNA. Circular dichroism studies indicated uniform orientation of heterocyclic bis-amidines along the chiral double helix axis, revealing minor groove binding as the dominant binding mode. The amidino fragment and 1, 4- bis(oxymethylene)phenyl spacer were the main determinants of activity against Trypanosoma brucei. The bis-benzimidazole imidazoline 15c, which had antitrypanosomal potency in the submicromolar range and DNA interacting properties, emerged as a candidate for further structural optimization to obtain more effective agents to combat trypanosome infections.
Izvorni jezik
Engleski
Znanstvena područja
Kemija
POVEZANOST RADA
Projekti:
HRZZ-IP-2018-01-4682 - Novi spojevi temeljeni na bioizosterima purina za ispitivanje njihovih antitumorskih i antipatogenih djelovanja (PurBioCaPa) (Raić-Malić, Silvana, HRZZ - 2018-01) ( CroRIS)
Ustanove:
Veterinarski fakultet, Zagreb,
Institut "Ruđer Bošković", Zagreb,
Fakultet kemijskog inženjerstva i tehnologije, Zagreb
Profili:
Silvana Raić-Malić
(autor)
Luka Krstulović
(autor)
Ivana Stolić
(autor)
Andrea Bistrović
(autor)
Lidija-Marija Tumir
(autor)
Miroslav Bajić
(autor)
Sanja Tomić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE